Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elba Etchebehere

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
American Journal of Nuclear Medicine and Molecular Imaging|July 17, 2023
Erratum: Single-center developing country analysis of radium-223 therapy in prostate cancer-preliminary resultsThaís B Minekawa, Allan O Santos, André G Moraes, et al.
Radiologia Brasileira|November 2, 2022
Interictal and postictal <sup>18</sup>F-FDG PET/CT in epileptogenic zone localizationMarcela Santos Carvalho, Marina Koutsodontis Machado Alvim, Elba Etchebehere, et al.
Oncotarget|April 19, 2017
18F-Fluoride PET/CT tumor burden quantification predicts survival in breast cancerAna E Brito, Allan Santos, André Deeke Sasse, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|August 9, 2018
Impact of 68GA-PSMA PET / CT on treatment of patients with recurrent / metastatic high risk prostate cancer - a multicenter studyAline B Mattiolli, Allan Santos, Andreia Vicente, et al.
Biomedicines|February 25, 2023
Does TRODAT-1 SPECT Uptake Correlate with Cerebrospinal Fluid α-Synuclein Levels in Mid-Stage Parkinson's Disease?Artur M Coutinho, Maria Gabriela Ghilardi, Ana Carolina P Campos, et al.
Radiologia Brasileira|October 4, 2021
The ratio between the whole-body and primary tumor burden, measured on <sup>18</sup>F-FDG PET/CT studies, as a prognostic indicator in advanced non-small cell lung cancerFelipe Renê Alves Oliveira, Allan de Oliveira Santos, Mariana da Cunha Lopes de Lima, et al.
Journal of Nuclear Medicine Technology|October 13, 2019
Validation of a Multifocal Segmentation Method for Measuring Metabolic Tumor Volume in Hodgkin LymphomaMariana R Camacho, Elba Etchebehere, Natalia Tardelli, et al.
Scientific Reports|November 13, 2019
Proposal for a Quantitative <sup>18</sup>F-FDG PET/CT Metabolic Parameter to Assess the Intensity of Bone Involvement in Multiple MyelomaMaria E S Takahashi, Camila Mosci, Edna M Souza, et al.
Journal of Nuclear Medicine Technology|April 20, 2022
Validation of Convolutional Neural Networks for Fast Determination of Whole-Body Metabolic Tumor Burden in Pediatric LymphomaElba Etchebehere, Rebeca Andrade, Mariana Camacho, et al.
Frontiers in Neurology|April 30, 2025
Quantitative SISCOM assessment for epileptogenic zone localization: insights from a multicenter study comparing two software platforms in temporal lobe epilepsyCarla Oliveira Young, Brunno Machado de Campos, Edna Marina de Souza, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
American Journal of Nuclear Medicine and Molecular Imaging|July 17, 2023
Erratum: Single-center developing country analysis of radium-223 therapy in prostate cancer-preliminary resultsThaís B Minekawa, Allan O Santos, André G Moraes, et al.
Radiologia Brasileira|November 2, 2022
Interictal and postictal <sup>18</sup>F-FDG PET/CT in epileptogenic zone localizationMarcela Santos Carvalho, Marina Koutsodontis Machado Alvim, Elba Etchebehere, et al.
Oncotarget|April 19, 2017
18F-Fluoride PET/CT tumor burden quantification predicts survival in breast cancerAna E Brito, Allan Santos, André Deeke Sasse, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|August 9, 2018
Impact of 68GA-PSMA PET / CT on treatment of patients with recurrent / metastatic high risk prostate cancer - a multicenter studyAline B Mattiolli, Allan Santos, Andreia Vicente, et al.
Biomedicines|February 25, 2023
Does TRODAT-1 SPECT Uptake Correlate with Cerebrospinal Fluid α-Synuclein Levels in Mid-Stage Parkinson's Disease?Artur M Coutinho, Maria Gabriela Ghilardi, Ana Carolina P Campos, et al.
Radiologia Brasileira|October 4, 2021
The ratio between the whole-body and primary tumor burden, measured on <sup>18</sup>F-FDG PET/CT studies, as a prognostic indicator in advanced non-small cell lung cancerFelipe Renê Alves Oliveira, Allan de Oliveira Santos, Mariana da Cunha Lopes de Lima, et al.
Journal of Nuclear Medicine Technology|October 13, 2019
Validation of a Multifocal Segmentation Method for Measuring Metabolic Tumor Volume in Hodgkin LymphomaMariana R Camacho, Elba Etchebehere, Natalia Tardelli, et al.
Scientific Reports|November 13, 2019
Proposal for a Quantitative <sup>18</sup>F-FDG PET/CT Metabolic Parameter to Assess the Intensity of Bone Involvement in Multiple MyelomaMaria E S Takahashi, Camila Mosci, Edna M Souza, et al.
Journal of Nuclear Medicine Technology|April 20, 2022
Validation of Convolutional Neural Networks for Fast Determination of Whole-Body Metabolic Tumor Burden in Pediatric LymphomaElba Etchebehere, Rebeca Andrade, Mariana Camacho, et al.
Frontiers in Neurology|April 30, 2025
Quantitative SISCOM assessment for epileptogenic zone localization: insights from a multicenter study comparing two software platforms in temporal lobe epilepsyCarla Oliveira Young, Brunno Machado de Campos, Edna Marina de Souza, et al.
Pageof 4